Michael Robert Cross is listed as an executive officer on 1 SEC Form D filing by 1 issuer in Jan 2025: Satellos Bioscience Inc. (Toronto, Ontario, Canada (as filed: A6) — biotechnology — 2025; $33.3M reported sold to 16 investors).
What this means One deal on file with the SEC, filed Jan 2025. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Adam Mostafa (1 shared filing), BRIAN M. BLOOM (1 shared filing), Bill Jarosz (1 shared filing), Courtney Wells (1 shared filing), ELIZABETH WILLIAMS (1 shared filing) and 8 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Michael. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 SEC release listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Michael Robert Cross and found 4 differences: Same name, different state: "Michael Cross" (NC) is a separate record; Same name, different state: "Michael Cross" (A1) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.